PAR
Click for more information
2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: Notice of Annual General Meeting/Proxy Form, page-8

  1. oxxa23
    5,962 Posts.
    lightbulb Created with Sketch. 1148
    clock Created with Sketch.
    04/10/19
    18:25
    Post #: 40733450
    I need to rejig the calendar, but, should get there... But, probably back to work after a quick hello pot or two.... away for 6 nights the week before...
    PAR Price at posting: $3.15 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
right-arrow Created with Sketch.
NEWS Is oil undervalued?
right-arrow Created with Sketch.
NXG Cost blow-out for Rook I uranium project sees share plummet for NexGen
right-arrow Created with Sketch.
MGU Collaboration in a green (steel) future the focus for Magnum and Saudi partners
right-arrow Created with Sketch.
NEWS Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
right-arrow Created with Sketch.
QBE QBE records share price plunge despite doubling profits in the first half of 2024
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢ 		Change
0.005(2.17%) 		Mkt cap ! $80.45M
Open High Low Value Volume
24.0¢ 25.0¢ 23.0¢ $99.20K 414.1K

Buyers (Bids)

No. Vol. Price($)
1 164 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 311 1
View Market Depth
Last trade - 15.59pm 09/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.